This HTML5 document contains 48 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n10http://dx.doi.org/10.1016/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n6http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q91895158
rdf:type
wikibase:Item
schema:description
scientific article published on 01 May 2019 article scientifique publié en 2019 wetenschappelijk artikel artículu científicu espublizáu en mayu de 2019 наукова стаття, опублікована 1 травня 2019
p:P577
wds:Q91895158-AC0CCFE2-D8E4-457A-ACCC-A15B81041860
wdt:P577
2019-05-01T00:00:00Z
p:P2093
wds:Q91895158-118E7D34-7E5E-412D-AD21-EBAF217552FA
wdt:P2093
Allan S Jaffe
rdfs:label
Galectin-3 Levels and Outcomes After Myocardial Infarction: A Population-Based Study Galectin-3 Levels and Outcomes After Myocardial Infarction: A Population-Based Study
skos:prefLabel
Galectin-3 Levels and Outcomes After Myocardial Infarction: A Population-Based Study Galectin-3 Levels and Outcomes After Myocardial Infarction: A Population-Based Study
schema:name
Galectin-3 Levels and Outcomes After Myocardial Infarction: A Population-Based Study Galectin-3 Levels and Outcomes After Myocardial Infarction: A Population-Based Study
p:P50
wds:Q91895158-F55FD955-F114-4708-AB3F-358CCB2EB1EB wds:Q91895158-39F7555F-B481-40C1-BC85-3F50D079BC45 wds:Q91895158-5095C235-6AE2-4CBB-A1E4-720C5551879E wds:Q91895158-5E4A0439-03C9-404A-8DF4-51AB4988BD67 wds:Q91895158-370F5EA4-3896-4F44-A4F9-31F2A0F69EC1 wds:Q91895158-877A9C52-97CA-4029-B81E-1973F0DDDC3C
wdt:P50
wd:Q110955107 wd:Q89718252 wd:Q114304348 wd:Q114354815 wd:Q114406465 wd:Q114360421
p:P1476
wds:Q91895158-88C8329D-173C-467A-B61C-FC1646016EFE
wdt:P1476
Galectin-3 Levels and Outcomes After Myocardial Infarction: A Population-Based Study
p:P304
wds:Q91895158-87BD06D7-D499-4DAF-B609-38F3CFFB73FF
wdt:P304
2286-2295
p:P31
wds:Q91895158-05F04FFA-BD0C-40F0-B71B-EE3A2466888D
wdt:P31
wd:Q13442814
p:P921
wds:Q91895158-485149AC-6E57-47F2-9D1F-9F81CA3C94CD
wdt:P921
wd:Q12152
p:P698
wds:Q91895158-854FF18D-CECD-4D6C-9CB3-9BA0376BACF5
wdtn:P698
n6:31072572
wdt:P698
31072572
p:P1433
wds:Q91895158-8771D573-BAEA-467C-B0F1-F09AD8F9F77F
wdt:P1433
wd:Q2984355
p:P433
wds:Q91895158-3688C657-D46D-48DC-8660-AC800F5BDE13
p:P478
wds:Q91895158-C4F666A8-021C-4956-B178-6C6C69BC452D
wdt:P433
18
wdt:P478
73
p:P356
wds:Q91895158-6EBEED51-B95A-4EA5-BCCC-95BBD8E72998
wdtn:P356
n10:J.JACC.2019.02.046
wdt:P356
10.1016/J.JACC.2019.02.046